Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
 
Register now or login to post to this thread.
  • Page:
  • 1

Cytomix??? (CYX)     

jonfish53 - 13 Jan 2004 10:03

Somthing not quite right here, Moneyam & Yahoo have a rise of 2110.5% to 31.5p
is this a mistake?

nathansmithba - 13 Jan 2004 12:29 - 4 of 11

nathansmithba - 13 Jan 2004 12:30 - 5 of 11

Seemingly not, my broker, with live positions, say that too

plumbob - 13 Jan 2004 22:02 - 6 of 11

Are these shares worth buying now

Mitch1967 - 15 Jan 2004 05:33 - 7 of 11

ding dong

p-snow - 08 Mar 2004 17:02 - 8 of 11

Has anyone got a view on CYX? Since getting on board in early January the share value has almost halved and the consolidation did nothing but cost me money. Apart from the 1.9m institutional share placing, a steady if unspectacular AGM, and a positive half page in SHARES magazine(26 Feb) there seems little reason for my poverty? Have I missed something or am I expecting too much too soon? What does it all mean? If you know something exciting please share it with me.

squidd - 09 Mar 2004 04:47 - 9 of 11

Despite 'strong buy' ratings from Hoodless Brennan and Seymour Pierce, Cytomediocre still looks like a dull company selling quack cures in some backwater. I've bailed out.
The Pharma that's really storming ahead is Elan, where director Kelly Martin, former head of a securuties division at Merril Lynch,has a big stake. I bought when he did, though it's now looking a bit late to climb aboard.

squidd - 09 Mar 2004 04:47 - 10 of 11

Despite 'strong buy' ratings from Hoodless Brennan and Seymour Pierce, Cytomediocre still looks like a dull company selling quack cures in some backwater. I've bailed out.
The Pharma that's really storming ahead is Elan, where director Kelly Martin, former head of a securuties division at Merril Lynch,has a big stake. I bought when he did, though it's now looking a bit late to climb aboard.

p-snow - 09 Mar 2004 08:37 - 11 of 11

Thanks squid, I won't say you've cheered me up but with this one any news is good news. With regards Elan, I'll put it down to experience and add it to the whole harbour full of boats I've just missed. Have a good week and thanks again.
  • Page:
  • 1
Register now or login to post to this thread.